cat
infect
virul
felin
coronaviru
caus
felin
infecti
periton
fip
usual
succumb
diseas
despit
high
antibodi
concentr
one
mechan
help
resolv
infect
antibodydepend
complementmedi
lysi
adcml
infect
cell
adcml
consist
virusspecif
antibodi
bind
cell
surfac
express
viral
protein
result
complement
activ
cell
lysi
object
studi
determin
sensit
fipviru
fipv
infect
cell
toward
adcml
examin
role
accessori
protein
process
adcml
assay
use
fipv
strain
delet
mutant
strain
perform
crfk
cell
show
surfaceexpress
viral
antigen
ii
monocyt
without
surfaceexpress
viral
protein
due
retent
iii
monocyt
surfaceexpress
viral
protein
sinc
antibodymedi
intern
protein
block
expect
adcml
detect
monocyt
without
surfaceexpress
viral
antigen
surprisingli
lysi
observ
crfk
cell
monocyt
show
surfaceexpress
viral
protein
control
show
adcml
assay
function
experi
proof
fipv
employ
anoth
immun
evas
strategi
adcml
besid
prevent
surfac
express
inhibit
complementmedi
lysi
new
evas
strategi
attribut
groupspecif
protein
sinc
lysi
cell
infect
fipv
detect
elsevi
bv
right
reserv
felin
infecti
periton
fip
fatal
diseas
character
fibrinousgranulomat
seros
often
proteinrich
effus
bodi
caviti
granulomatousnecrotis
phlebiti
periphleb
granulomat
inflammatori
lesion
sever
organ
weiss
scott
b
kipar
et
al
kipar
et
al
caus
agent
virul
form
felin
coronavirus
fcov
belong
famili
coronavirida
order
nidoviral
vivo
monocyt
tissu
macrophag
target
cell
play
central
role
develop
lesion
kipar
et
al
infect
cell
excel
target
immun
system
fight
infect
howev
case
immun
respons
protect
cat
succumb
infect
cellmedi
immun
believ
import
control
clearanc
fipviru
fipv
infect
effici
first
respons
infect
humor
immun
respons
believ
protect
high
concentr
neutral
antibodi
present
cat
endstag
fip
differ
seen
antibodi
concentr
fluctuat
survivor
nonsurvivor
fipv
infect
de
grootmijn
et
al
gener
virusspecif
antibodi
help
resolv
infect
antibodymedi
lysi
infect
cell
via
cytolyt
immun
cell
fc
receptor
like
nk
cell
macrophag
neutrophil
via
complement
sisson
oldston
complement
system
immunolog
defens
system
play
role
innat
adapt
immun
respons
invad
pathogen
complement
consist
serum
membranebound
protein
activ
trigger
biochem
cascad
reaction
contribut
erad
pathogen
blue
et
al
import
complement
effector
function
opson
pathogen
cytolysi
promot
host
inflammatori
respons
anaphylatoxin
chemotaxin
product
janeway
et
al
viral
infect
complement
system
activ
free
viru
particl
virusinfect
cell
complement
inactiv
free
viru
presenc
absenc
antibodi
opson
viru
complement
protein
promot
phagocytosi
virolysi
interfer
attach
intern
uncoat
virion
hirsch
cell
infect
envelop
virus
lyse
complement
presenc
antibodi
newli
synthes
viral
glycoprotein
express
plasma
membran
infect
cell
virusspecif
antibodi
bind
surfaceexpress
protein
therebi
activ
complement
system
eventu
result
cell
death
sisson
oldston
process
call
antibodydepend
complementmedi
lysi
adcml
recent
describ
fipv
two
process
inhibit
express
viral
protein
plasma
membran
vitro
infect
monocyt
name
retent
viral
protein
infect
cell
antibodymedi
intern
surfaceexpress
viral
protein
process
result
clearanc
detect
viral
antigen
plasma
membran
infect
cell
dewerchin
et
al
dewerchin
et
al
fipvinfect
monocytesmacrophag
isol
natur
infect
cat
express
viral
protein
plasma
membran
either
cornelissen
et
al
absenc
viral
protein
plasma
membran
infect
monocyt
protect
infect
cell
effici
adcml
describ
pseudorabi
viru
prv
equin
porcin
reproduct
respiratori
syndrom
viru
prrsv
van
der
meulen
et
al
van
de
wall
et
al
coster
et
al
object
studi
determin
effici
adcml
fipvinfect
cell
show
surfaceexpress
viral
antigen
sinc
would
open
treatment
possibl
base
inhibit
antibodymedi
intern
surfaceexpress
viral
antigen
furthermor
role
accessori
protein
assess
context
adcml
assay
crandel
felin
kidney
cell
crfk
peripher
blood
monocyt
perform
crfk
seed
sixwel
plate
nunc
cultiv
memmedium
contain
fetal
bovin
serum
fb
lactalbumin
mgml
glutamin
uml
penicillin
mgml
streptomycin
mgml
kanamycin
peripher
blood
monocyt
isol
felin
coronaviru
felin
leukemia
viru
felin
immunodefici
viru
neg
cat
describ
previous
dewerchin
et
al
cultiv
sixwel
plate
rpmi
contain
fb
mgml
glutamin
uml
penicillin
mgml
streptomycin
mgml
kanamycin
uml
heparin
mm
sodium
pyruv
nonessenti
amino
acid
gibco
brl
cell
infect
fipv
type
ii
strain
attenu
delet
mutant
viru
strain
fipv
multipl
infect
virus
kindli
provid
dr
rottier
faculti
veterinari
medicin
utrecht
univers
netherland
delet
mutant
strain
fipv
strain
open
read
frame
delet
use
revers
genet
haijema
et
al
crfk
monocyt
mechan
detach
gentli
pipet
well
h
postinocul
hpi
hpi
respect
perform
assay
suspens
cell
incub
h
fipvspecif
polyclon
antibodi
pab
mgml
antibodi
purifi
fipvneg
serum
mgml
fipvspecif
pab
origin
cat
infect
fipv
provid
dr
rottier
fipvneg
serum
deriv
fcovneg
cat
ipma
antibodi
titer
pab
purifi
use
protein
asepharos
amersham
bioscienc
cell
wash
incub
complement
noninactiv
serum
fcovneg
cat
cell
stain
ethidium
monoazid
bromid
ema
molecular
probe
label
dead
cell
fix
paraformaldehyd
vwr
permeabil
saponin
sigma
stain
specif
monoclon
antibodi
mab
fipv
nucleocapsid
n
protein
membran
protein
follow
fitclabel
goat
antimous
igg
molecular
probe
identifi
fipvinfect
cell
mab
recogn
n
protein
produc
character
laboratori
nuclei
stain
hoechst
molecular
probe
dead
infect
cell
count
use
fluoresc
microscopi
monocyt
antibodyinduc
intern
inhibit
pretreat
min
myosin
light
chain
kinas
inhibitor
inclus
inhibitor
antibodi
complement
incub
dewerchin
sinc
antibodi
must
bound
cell
adcml
occur
immunofluoresc
stain
perform
determin
presenc
antibodi
surfac
infect
cell
cell
fix
paraformaldehyd
incub
fipvspecif
pab
antibodi
stain
fitclabel
goat
anticat
igg
sigma
permeabil
saponin
infect
cell
stain
nand
mspecif
mab
texa
redlabel
goat
antimous
igg
molecular
probe
nuclei
stain
hoechst
molecular
probe
two
control
assay
perform
verifi
function
adcml
assay
fipv
neutral
assay
detect
higher
neutral
presenc
complement
order
confirm
activ
felin
complement
combin
fipvspecif
pab
ii
adcml
assay
pseudorabi
viru
prv
infect
felin
monocyt
crfk
confirm
activ
felin
complement
sensit
cell
adcml
exclud
possibl
interfer
use
media
adcml
assay
perform
describ
use
prv
strain
kaplan
felin
pab
prv
deriv
geskypur
merial
vaccin
fcovneg
cat
accord
manufactur
instruct
felin
complement
fitclabel
prvspecif
pab
identifi
infect
cell
describ
prvinfect
porcin
macrophag
surfaceexpress
viral
antigen
sensit
adcml
van
de
wall
et
al
result
adcml
fipv
delet
mutant
viru
strain
fipv
given
fig
virus
cell
type
percentag
dead
fipvinfect
cell
adcml
assay
virusspecif
antibodi
significantli
differ
assay
without
antibodi
p
also
signific
differ
seen
adcml
assay
fipvneg
antibodi
triplic
assay
perform
result
compar
use
friedman
test
spss
softwar
packag
version
spss
inc
presenc
fipvspecif
antibodi
surfac
infect
cell
similar
fipv
fipv
infect
crfk
show
surfacebound
antibodi
format
small
aggreg
seen
approxim
onefourth
cell
fig
cell
show
larger
aggreg
patch
fig
infect
monocyt
show
surfacebound
antibodi
approxim
two
third
cell
show
small
antibodi
aggreg
fig
remain
cell
show
homogen
antibodi
distribut
fig
mean
cell
protect
adcml
irrespect
express
viral
protein
surfac
perform
control
show
combin
antibodi
complement
effect
neutral
fipv
cell
sensit
adcml
presenc
complement
viru
neutral
titer
two
time
time
higher
tcid
fipv
respect
adcml
assay
prv
show
adcml
effect
crfk
felin
monocyt
cell
type
signific
rise
percentag
dead
cell
higher
antibodi
concentr
p
friedman
test
fig
humor
immun
system
activ
fipv
infect
antibodi
form
seem
ineffect
elimin
viru
virusinfect
cell
fipvinfect
cell
antibodymedi
intern
plasma
membraneexpress
viral
protein
describ
dewerchin
et
al
intern
result
absenc
viral
protein
plasma
membran
protect
infect
cell
effici
adcml
inhibit
intern
process
result
infect
cell
recogniz
antibodi
could
part
treatment
protocol
fip
cat
unfortun
result
studi
show
even
viral
protein
present
plasma
membran
lysi
occur
adcml
howev
antibodi
bind
surfaceexpress
viral
protein
cell
lysi
may
still
occur
via
cell
lysi
mechan
eg
via
antibodydepend
cellmedi
cytotox
mechan
lysi
perform
activ
natur
killer
cell
neutrophil
monocyt
macrophag
lysi
virusinfect
cell
antibodi
complement
requir
viral
protein
express
form
configur
recogniz
antibodi
bind
complement
hirsch
fipvspecif
antibodi
use
abl
bind
complement
sinc
virusneutr
higher
presenc
complement
higher
neutral
due
virolysi
agglutin
virusantibodycompl
complex
coat
viru
complement
compon
interfer
bind
viru
target
cell
alter
surfac
charg
viru
hirsch
lachmann
davi
exampl
could
possibl
bind
complement
fc
portion
antibodi
inhibit
antibodydepend
enhanc
infect
adei
mechan
describ
vitro
hohdatsu
et
al
fact
neutral
antibodi
present
cat
fip
togeth
observ
enhanc
neutral
complement
studi
indic
cell
free
viru
play
import
role
pathogenesi
fip
de
grootmijn
et
al
effect
adcml
amount
bound
antibodi
also
import
antibodi
bound
surfac
infect
cell
higher
percentag
lyse
cell
fipvinfect
crfk
show
bound
antibodi
surfac
format
patch
like
influenc
adcml
assay
describ
measl
virusinfect
cell
redistribut
viral
antigen
influenc
effect
adcml
half
infect
monocyt
show
bound
antibodi
surfac
consist
previous
publish
result
dewerchin
et
al
expect
monocyt
without
surfaceexpress
viral
protein
protect
adcml
also
adcml
seen
monocyt
surfaceexpress
viral
protein
possibl
insuffici
amount
antibodi
bound
infect
crfk
monocyt
detect
effect
adcml
unlik
complet
exclud
seem
fipv
employ
anoth
viru
complement
evas
strategi
addit
alreadi
describ
retent
viral
protein
cytoplasm
infect
cell
antibodymedi
intern
plasma
membraneexpress
viral
protein
addit
evas
strategi
attribut
accessori
groupspecif
protein
sinc
lysi
cell
infect
doubl
mutant
strain
fipv
detect
gene
encod
protein
necessari
viru
growth
infect
delet
attenu
effect
virul
viru
cat
haijema
et
al
basi
attenu
known
correl
efficaci
adcml
shown
present
studi
new
immun
evas
strategi
attribut
structur
protein
nonstructur
protein
orf
direct
via
viral
protein
indirect
mean
cellular
protein
regul
complement
cascad
variou
viru
complement
evas
strategi
describ
virus
virus
express
protein
fc
receptor
activ
inhibit
bind
complement
antibodyantigen
complex
glycoprotein
ge
express
herp
simplex
viru
hsv
fc
receptor
activ
protect
antibodi
complementmedi
lysi
vitro
vivo
adler
et
al
lubinski
et
al
fipv
presenc
fc
receptor
activ
never
studi
spike
protein
coronavirus
name
mous
hepat
viru
mhv
bovin
coronaviru
bcv
transmiss
gastroenter
viru
tgev
display
fc
receptor
activ
oleszak
et
al
anoth
possibl
viru
encod
protein
function
similar
complement
control
protein
inhibitor
complement
cascad
viral
complement
control
protein
describ
coronavirus
sever
describ
poxvirus
herpesvirus
bernet
et
al
fipv
would
impli
spike
membran
envelop
protein
nonstructur
protein
encod
orf
exhibit
complement
control
protein
activ
like
bind
acceler
decay
certain
complement
factor
final
possibl
viru
induc
upregul
host
complement
control
factor
infect
cell
describ
human
cytomegaloviru
hcmv
upregul
complement
regul
protect
infect
cell
complementmedi
lysi
spiller
et
al
fipv
occur
two
type
type
ii
type
prevail
field
pedersen
type
caus
clinic
fip
evad
immun
system
cat
result
studi
obtain
type
ii
strain
whether
cell
infect
type
strain
also
show
inhibit
complementmedi
lysi
determin
differ
outcom
possibl
sinc
evas
strategi
could
attribut
protein
main
differ
type
ii
found
protein
herrewegh
et
al
conclus
state
fipvinfect
cell
protect
adcml
cell
without
surfaceexpress
viral
protein
appear
evolut
fipv
becom
master
disguis
exhibit
sever
immun
evas
mechan
avoid
clearanc
infect
cell
humor
immun
respons
